Vertex Pharmaceuticals SVP & CAO Kristen Ambrose Granted 5,000 RSUs
VERTEX PHARMACEUTICALS INC / MA
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Filing: Vertex Pharmaceuticals Inc ($VRTX) • Insider: Kristen Ambrose (SVP & Chief Accounting Officer) • Transaction Date: August 28, 2026 • Action: Award / Grant (RSU) • Shares: 5,000 Common Stock @ $0.00 • Direct Holdings Post-Transaction: 11,624 shares • Significance: Low (Routine Equity Grant)
Comprehensive Analysis
Executive Summary
On September 1, 2026, Kristen Ambrose, Senior Vice President & Chief Accounting Officer of Vertex Pharmaceuticals Inc ($VRTX), reported an acquisition of 5,000 shares of Common Stock on August 28, 2026.
Transaction Breakdown
- Transaction Code:
A(Grant, award, or other acquisition under Rule 16b-3). - Security Type: Common Stock (Restricted Stock Unit award).
- Shares Acquired: 5,000 shares.
- Transaction Price: $0.00 per share.
- Post-Transaction Beneficial Ownership: 11,624 shares held directly.
- Vesting Terms: According to footnote (1), the restricted stock unit award is scheduled to cliff vest on March 1, 2029.
Market Impact & Significance
This transaction is categorized as Low Significance from an investment and trading perspective because it represents a standard compensatory restricted stock unit (RSU) award rather than an open-market purchase or sale. It reflects routine executive compensation and long-term equity alignment rather than directional market sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.